Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 15;196(4):1700-10.
doi: 10.4049/jimmunol.1502137. Epub 2016 Jan 15.

Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques

Affiliations

Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques

Diego A Vargas-Inchaustegui et al. J Immunol. .

Abstract

Measurement of Ag-specific T follicular helper (TFH) cell activity in rhesus macaques has not previously been reported. Given that rhesus macaques are the animal model of choice for evaluating protective efficacy of HIV/SIV vaccine candidates and that TFH cells play a pivotal role in aiding B cell maturation, quantifying vaccine induction of HIV/SIV-specific TFH cells would greatly benefit vaccine development. In this study, we quantified SIV Env-specific IL-21-producing TFH cells for the first time, to our knowledge, in a nonhuman primate vaccine study. Macaques were primed twice mucosally with adenovirus 5 host range mutant recombinants encoding SIV Env, Rev, Gag, and Nef followed by two i.m. boosts with monomeric SIV gp120 or oligomeric SIV gp140 proteins. At 2 wk after the second protein boost, we obtained lymph node biopsy specimens and quantified the frequency of total and SIV Env-specific IL-21(+) TFH cells and total germinal center B cells, the size and number of germinal centers, and the frequency of SIV-specific Ab-secreting cells in B cell zones. Multiple correlation analyses established the importance of TFH for development of B cell responses in systemic and mucosally localized compartments, including blood, bone marrow, and rectum. Our results suggest that the SIV-specific TFH cells, initially induced by replicating adenovirus-recombinant priming, are long lived. The multiple correlations of SIV Env-specific TFH cells with systemic and mucosal SIV-specific B cell responses indicate that this cell population should be further investigated in HIV vaccine development as a novel correlate of immunity.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Phenotypic characterization of macaque IL-21-producing TFH cells
Inguinal lymph nodes (LN) were collected, processed into single-cell suspensions, and used fresh for flow cytometry phenotypic analysis. (A) Gating strategy used to define LN-resident TFH cells as live CD3+CD4+CCR7ICOS+PD-1hi in naïve (top) and SIV-infected (bottom) rhesus macaques. (B) Percentage of TFH cells in naïve and SIV-infected macaques. (C) IL-21 production by TFH cells in response to PMA/Ionomycin treatment. (D) Percent of IL-21-producing TFH cells in naïve and SIV-infected macaques. (E) CTLA-4, CD40L and CD95 expression in IL-21+ TFH cells (red histograms) compared to non-TFH cells (naïve CD4+ T cells, blue histograms). Data reported are means ± SEM. ***, p<0.001 indicates statistically significant differences between the compared groups by the Mann-Whitney test.
Fig. 2
Fig. 2. Correlation between humoral responses and TFH cell abundance in vaccinated rhesus macaques
(A) Percentage of TFH cells in the inguinal LN of vaccinated and control macaques at week 53 of the study. Data reported are means ± SEM. (B) Correlation between abundance of total LN TFH cells at week 53 and SIV Env-specific memory B cells in the bone marrow at week 53 in vaccinated macaques. Spearman’s correlation analysis was used to determine statistical significance. Env-specific memory B cell data are from ref. 32.
Fig. 3
Fig. 3. Effect of vaccination on GC size and TFH cell number
(A-F) LN biopsies from a subset of vaccinated macaques were collected at week 53 and fixed in 10% formalin prior to paraffin embedding. (A-B) Tissue sections were recovered and stained specifically with Ki67, CD20 and CD4 to identify and measure the size of GCs (A), and with CD4, PD-1 and Ki67 to identify and enumerate GC-resident TFH cells (B). Bars represent 100 and 50μm in A and B, respectively. (C-D) The number of GCs (C) and the average GC area per animal (D) were measured in LN sections as displayed in A with Aperio ImageScope Quantification Software. (E-F) Confocal images of LN sections stained as in B were analyzed as described in Materials and Methods to determine PD-1 and CD4 expression intensity levels on an individual cell basis. Gates (red line) were drawn to enumerate TFH (PD-1hiCD4+) cells per GC (E) and to compare between vaccinated and control macaques (F). Data reported are means ± SEM
Fig. 4
Fig. 4. Effect of vaccination on GC-resident B cell subpopulations
(A-D) Frozen inguinal lymph node cells from controls and vaccinated macaques were thawed and stained (A) in order to identify the absolute population of IgDCD20+Bcl6+ GC cells (B), IgDCD20+Bcl6+Ki67hi centroblasts (C) and IgDCD20+Bcl6+Ki67neg/lo centrocytes (D) by flow cytometry. Data reported are means ± SEM.
Fig. 5
Fig. 5. Correlations between GC parameters and GC B cells with humoral immune responses and total TFH cells
Correlations in vaccinated macaques between the number of histologically-determined GCs in the LN at week 53 and the abundance of flow cytometry-determined absolute TFH cells at week 53 (A), SIV-specific gp120 and gp140 serum binding titers at week 57 (B) and SIV Env-specific IgA activity in bone marrow at week 53 (C). Correlations between the number of histologically-determined TFH cells per GC at week 53 and the number of GCs per LN (D), the average GC area (E), and the abundance of TFH cells as determined by flow cytometry (F). (G-H) Correlation analyses of the abundance of flow cytometry-determined TFH cells and the abundance of IgDCD20+Bcl6+ GC B cells (G) and IgDCD20+Bcl6+Ki67hi GC centroblasts (H) at week 53. Note, histologically-determined GC data were obtained on only half of the vaccinated and control macaques as described in Materials and Methods. Spearman’s correlation analysis was used to determine statistical significance. Humoral immune response data are from ref. 32.
Fig. 6
Fig. 6. SIV-specific production of IL-21 by TFH cells in vaccinated rhesus macaques
(A) IL-21 production by LN-resident TFH cells of vaccinated and SIV+ macaques in response to SIV envelope peptide stimulation. (B) CTLA-4, CD40L and CD95 expression by IL-21+ SIV-specific TFH cells. SIVsmH4- (C) and SIVmac239-specific (D) IL-21 production by TFH cells at week 53 post-vaccination. Vaccinated data in C and D include macaques of both vaccination groups. Data reported are means ± SEM. **, p<0.01 indicates statistically significant differences between the indicated time points by the Wilcoxon signed rank test.
Fig. 7
Fig. 7. Correlation between SIV-specific humoral responses and SIV-specific TFH cell activity
(A-H) Correlations between SIVsmH4-specific IL-21 production by LN-resident TFH cells at week 53 post-vaccination and SIVgp140-specific week 53 serum binding titers (A), SIV251.6 neutralizing antibodies in serum at week 53 (B), gp140- and gp120-specific IgG1 (C) and IgG3 (D) end point titers measured by ELISA, SIVgp140-specific IgA (E) and IgG (F) antibodies in rectal secretions at week 53 as measured by ELISA, IgG Env-specific memory B cell activity in bone marrow at week 57 as measured by ELISPOT (G) and gp140- and gp120-specific 50% maximum killing ADCC titers as measured by the RFADCC assay (H). Spearman’s correlation analysis was used to determine statistical significance. Humoral immune response data are from ref. 32.
Fig. 8
Fig. 8. Total and SIV Env-specific TFH cell responses in female versus male rhesus macaques
(A) Abundance of total TFH cells before and after vaccination in male and female rhesus macaques. *, p<0.05 indicates statistically significant differences between the indicated groups by the Mann-Whitney test. (B) Vaccine-induced SIVsmH4 Env-specific IL-21+ TFH cells in male and female rhesus macaques. **, p<0.01 and *, p<0.05 indicate statistically significant differences between the indicated time points by the Wilcoxon signed rank test. Data reported are means ± SEM. (C-D) Correlations between total TFH cells at week 53 post-vaccination and gp120-specific serum binding titer at week 57 as measured by ELISA (C), and the abundance of rectal plasmablasts 2 weeks post-infection (D) in vaccinated female macaques. Correlation between SIVsmH4-specific IL-21 production by LN-resident TFH cells at week 53 post-vaccination and gp120-specific 50% maximum killing ADCC titers as measured by the RFADCC assay in vaccinated female macaques. Spearman’s correlation analysis was used to determine statistical significance. Humoral immune response data are from ref. 32.
Fig. 9
Fig. 9. Histological identification of SIV-specific B cells in the LN of vaccinated macaques
LN biopsies from a subset of vaccinated macaques were collected at week 53 and fixed in 10% formalin prior to paraffin embedding. (A) Tissue sections were recovered, processed and stained for inverse-IHC using biotin-SIVgp120 or gp140. Images were captured using a ScanScope Slide scanner and analyzed using ImageScope software. Graph represents the number of SIV-specific antibody secreting cells (ASC) per mm2 of LN B cell zone. Data reported are means ± SEM. (B) Correlation between the number of SIV-specific ASC at week 53 and the plasma viral load at week 1 post-infection in female macaques (from ref. 32). Spearman’s correlation analysis was used to determine statistical significance.

References

    1. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17:1055–1065. - PMC - PubMed
    1. Plotkin SA. Vaccination against the major infectious diseases. C R Acad Sci III. 1999;322:943–951. - PubMed
    1. Klein F, Mouquet H, Dosenovic P, Scheid JF, Scharf L, Nussenzweig MC. Antibodies in HIV-1 vaccine development and therapy. Science. 2013;341:1199–1204. - PMC - PubMed
    1. McGuire AT, Dreyer AM, Carbonetti S, Lippy A, Glenn J, Scheid JF, Mouquet H, Stamatatos L. HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies. Science. 2014;346:1380–1383. - PMC - PubMed
    1. Stamatatos L, Morris L, Burton DR, Mascola JR. Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat Med. 2009;15:866–870. - PubMed

Publication types

MeSH terms

LinkOut - more resources